CDKN1A and cancer: Regarding Gartel, who proposed in 2009 the idea of ‘antagonistic duality’ for p21 in cancer, acting as an oncogene or as a tumor suppressor gene in a context-dependent manner, this paradox might explain why p21 is not qualified as a prognostic marker in CRC [38].